02 October 2003
Effect of ionic strength of buffer on the measurement of erythrocyte electrophoretic mobility
Nesrin Zeynep Ertan, Michael W. RamplingMed Sci Monit 2003; 9(10): BR378-381 :: ID: 13248
Abstract
Background:Measurement of the electrophoretic mobility (EM) of biological cells provides information on the electrical properties of the cell surface. Different research groups have used different electrophoretic techniques. It is well known that the osmolality of the buffer used during an experiment exerts a major impact on EM, particularly in biological cells. In previous experiments either high or low ionic strength electrophoresis buffers were used with an arbitrary preference. The aim of this study is to investigate which buffer is more useful for EM measurements, and hence to give greater insight into the results of such experiments.Material/Methods:Blood was drawn from healthy volunteers. Two different buffers were prepared: low ionic and high ionic. Twenty molarity steps were prepared by mixing the buffers in different ratios. Measurements were made using a Zetasizer.Results:Our data confirmed that the EM fell as ionic strength increased. However, the relationship was biphasic: the first ten points were linear with a steep negative slope and the second set also linear but with a much smaller slope.Conclusions:EM studies usually have one of two extreme aims: either to compare the inherent surface electrical properties of cells from different sourses at the same ionic strength, or to study the influence of different ionic environments on the surface electrical properties of cells from the source. Our data suggest that in the first instance it is better to work at high ionic strength. In the second, low ionic strength is preferable.
Keywords: Blood Chemical Analysis - methods, Buffers, Cell Membrane - metabolism, Electrophoresis, Erythrocytes - chemistry, Ions
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952